OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting IL-36 in Inflammatory Skin Diseases
Ryo Fukaura, Masashi Akiyama
BioDrugs (2023) Vol. 37, Iss. 3, pp. 279-293
Closed Access | Times Cited: 29
Ryo Fukaura, Masashi Akiyama
BioDrugs (2023) Vol. 37, Iss. 3, pp. 279-293
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 127
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 127
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Nagoya Journal of Medical Science
JAMA (1964) Vol. 188, Iss. 11, pp. 234-234
Open Access | Times Cited: 178
JAMA (1964) Vol. 188, Iss. 11, pp. 234-234
Open Access | Times Cited: 178
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 801-801
Open Access | Times Cited: 37
Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 801-801
Open Access | Times Cited: 37
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 30
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 30
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Targeted review of IL36RN mutations in patients with generalised pustular psoriasis
James G. Krueger, Anna Pagotto, Samuel Haftel, et al.
Skin Health and Disease (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 6
James G. Krueger, Anna Pagotto, Samuel Haftel, et al.
Skin Health and Disease (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 6
Spesolimab for the Treatment of Generalized Pustular Psoriasis
Diana Bernardo, Diamant Thaçi, Tiago Torres
Drugs (2023) Vol. 84, Iss. 1, pp. 45-58
Open Access | Times Cited: 16
Diana Bernardo, Diamant Thaçi, Tiago Torres
Drugs (2023) Vol. 84, Iss. 1, pp. 45-58
Open Access | Times Cited: 16
The emerging role of IL‐38 in diseases: A comprehensive review
Weijun Chen, Shuangyun Xi, Y. Ke, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 11
Weijun Chen, Shuangyun Xi, Y. Ke, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 11
Successful Treatment of Three Patients with Generalized Pustular Psoriasis and a Retrospective Review of Asian Patient Cases by Spesolimab
晓晖 纪
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 997-1003
Closed Access
晓晖 纪
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 997-1003
Closed Access
Interleukins in the Pathogenesis of Warts: Insight from the Last Decade—A Narrative Review
Clara Matei, Laura Sorina Diaconu, Mircea Tampa
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2057-2057
Open Access
Clara Matei, Laura Sorina Diaconu, Mircea Tampa
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2057-2057
Open Access
Monocytes Expressing IL ‐36G Play a Crucial Role in Atopic Dermatitis
Yitao Yang, Lei Wang, Longmei Yu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Yitao Yang, Lei Wang, Longmei Yu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Update on Generalized Pustular Psoriasis
Tiago Torres, Joana Antunes, Rui Tavares Bello, et al.
Acta Médica Portuguesa (2025) Vol. 38, Iss. 5, pp. 321-330
Open Access
Tiago Torres, Joana Antunes, Rui Tavares Bello, et al.
Acta Médica Portuguesa (2025) Vol. 38, Iss. 5, pp. 321-330
Open Access
Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments.
Masashi Akiyama
PubMed (2024) Vol. 86, Iss. 1, pp. 1-15
Closed Access | Times Cited: 3
Masashi Akiyama
PubMed (2024) Vol. 86, Iss. 1, pp. 1-15
Closed Access | Times Cited: 3
Current therapeutic overview and future perspectives regarding the treatment of psoriasis
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113388-113388
Closed Access | Times Cited: 3
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113388-113388
Closed Access | Times Cited: 3
Pro‐inflammatory cytokine IL‐6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathway
Zhenzhen Tu, Wei Wei, Qiantong Xiang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 12
Open Access | Times Cited: 8
Zhenzhen Tu, Wei Wei, Qiantong Xiang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 12
Open Access | Times Cited: 8
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 76-76
Open Access | Times Cited: 2
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 76-76
Open Access | Times Cited: 2
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
Kristine Heidemeyer, Marco May Lee, Simone Cazzaniga, et al.
Psoriasis Targets and Therapy (2023) Vol. Volume 13, pp. 33-58
Open Access | Times Cited: 6
Kristine Heidemeyer, Marco May Lee, Simone Cazzaniga, et al.
Psoriasis Targets and Therapy (2023) Vol. Volume 13, pp. 33-58
Open Access | Times Cited: 6
Spesolimab: a comprehensive review on the anti‐IL ‐36 receptor antibody in dermatology
Vijayasankar Palaniappan, Hima Gopinath, Aravind Baskar Murthy, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 88-93
Closed Access | Times Cited: 4
Vijayasankar Palaniappan, Hima Gopinath, Aravind Baskar Murthy, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 88-93
Closed Access | Times Cited: 4
Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis
Romane Teshima, Natsuko Saito‐Sasaki, Taiyo Hitaka, et al.
Cureus (2024)
Open Access | Times Cited: 1
Romane Teshima, Natsuko Saito‐Sasaki, Taiyo Hitaka, et al.
Cureus (2024)
Open Access | Times Cited: 1
Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis
Ziqin Cao, Qiangxiang Li, Yajia Li, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Ziqin Cao, Qiangxiang Li, Yajia Li, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
Martina D’Onghia, Dalma Malvaso, Giulia Galluccio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5211-5211
Open Access | Times Cited: 1
Martina D’Onghia, Dalma Malvaso, Giulia Galluccio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5211-5211
Open Access | Times Cited: 1
Interleukin 38 reduces antigen-presentation capacity and antibody production after vaccination
Lisa U. Teufel, Esther Taks, Jelle van Gemert, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126396-126396
Open Access | Times Cited: 1
Lisa U. Teufel, Esther Taks, Jelle van Gemert, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126396-126396
Open Access | Times Cited: 1
Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease
Masashi Akiyama
The Journal of Dermatology (2024)
Open Access | Times Cited: 1
Masashi Akiyama
The Journal of Dermatology (2024)
Open Access | Times Cited: 1
The impact of current investigational drugs for acne on future treatment strategies
Heli Patel, Lily Guo, Steven R. Feldman
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 2, pp. 127-132
Closed Access
Heli Patel, Lily Guo, Steven R. Feldman
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 2, pp. 127-132
Closed Access
